Why Guardant Health Stock Skyrocketed 21% Today
Shares of Guardant Health (NASDAQ: GH) skyrocketed 21% on Wednesday. This huge gain came after the precision oncology company announced great second-quarter results after the market closed on Tuesday.
Guardant Health reported Q2 revenue of $54 million, a whopping 178% increase over the prior-year period. The consensus analysts' estimate was for Q2 revenue of $36.4 million. The company also revised its full-year 2019 revenue guidance to between $180 million and $190 million, up from the previous range of $145 million to $150 million.
Image source: Getty Images.
Quelle Fool.com
